Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, and Autolomous, a cloud-based, ...

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

The approval was based on results from the TROPION-Breast01 Phase III trial.

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately.